CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Accord Healthcare against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Jul 31, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Manufacture Of DegarelixFERRINGApr 10, 2025
Methods Of Treating Hepatic Encephalopathy Using RifaximinSALIX PHARMACEUTICALSNov 14, 2024
Novel Antitumoral Use Of CabazitaxelAVENTIS PHARMAAug 30, 2024
Dosing Regimen For Missed Doses For Long-Acting Injectable Paliperidone EstersJANSSEN PHARMACEUTICAAug 28, 2024
Method For Suppressing Bitterness Of Quinoline DerivativeEISAI R&D MANAGEMENTJul 25, 2024
Safe And Effective Method Of Treating Ulcerative Colitis With Anti-Il12/Il23 AntibodyJANSSEN BIOTECHApr 12, 2024
Subcutaneous Anti-Her2 Antibody FormulationF HOFFMANN LA ROCHEFeb 12, 2024
Method For Producing A Bortezomib Ester SolutionSTADA ARZNEIMITTELJun 28, 2023
Ready-To-Use Bortezomib SolutionSTADA ARZNEIMITTELMay 17, 2023
High-Purity Quinoline Derivative And Method For Manufacturing SameEISAI R&D MANAGEMENTMay 10, 2023

Top competitors of Accord Healthcare

List of top competitors of Accord Healthcare based on patent oppositions.